Logo

Sign in | Create an Account Cart 0
Sign In
Forgot password?
Institutional Users can Sign In here
Don't have an Account?
Create an account
 
Forgot Password
 
Thank You for Registration

Thank-you for creating an account on Longwoods.com.

As a registered user of longwoods.com you can receive the following benefits:
  • Abstracts from ALL Longwoods.com publications
  • Citation tracking and reference links to full-text articles
  • Ability to share the information through various social media outlets with a single click
  • Ability to comment on any article
  • Pay-per-View purchases of single articles or issues by credit card or paypal
  • Choice of any www.longwoods.com/newsletters delivered to your email inbox for free
  • Ability to sign up for any www.longwoods.com/events.
  • The advantage of having password access to www.Longwoods.com from any computer anywhere
Please check your e-mail and follow the instructions to activate your account. If you do not receive an e-mail, please check your junk folder.
Reset Password

Please check your e-mail and follow the instructions to reset your password.

Menu
  • Home
  • Topics
    • Access to Care
    • Aging
    • Alternative Levels of Care
    • Caregivers
    • Change Management
    • Community Care
    • COVID-19
    • Decision Making
    • Digital Health
    • Effective Teamwork
    • Equity in Healthcare
    • Governance
    • Health Human Resources
    • Health System Innovation
    • Healthcare Costs
    • Healthcare Policy
    • Healthy workplaces
    • Home Care
    • Innovations in Care
    • Leadership Development
    • Long-Term Care
    • Longwoods Healthcare Services Radio
    • Mental Health
    • Nursing Leadership
    • Pandemic Planning
    • Patient Experience
    • Patient Safety
    • Patient-Centered Care
    • Primary Care
    • Public Health
    • Quality Improvement
    • System Integration
    • Workforce Planning
  • Events
    • Longwoods Breakfast Series
    • Healthcare Rounds
    • Leadership Discussion
    • Conferences and Education
    • Healthcare Awards
  • Publications
    • Healthcare Quarterly
    • HealthcarePapers
    • Healthcare Policy
    • Nursing Leadership
    • Insights
    • Special Issues
    • White Papers
    • Longwoods Blog
    • World Health & Population
    • ElectronicHealthcare
    • Law & Governance
    • Books
  • Multimedia
    • Videos
    • Podcasts
  • Jobs
    • Longwoods Job Site
    • HR Resources Database
    • Transitions
    • Rates for Job Postings
  • Subscribe

Health & Healthcare News

U of A researchers on cusp of developing simple blood test to pinpoint which pregnant women will develop preeclampsia


EDMONTON, Sept. 13 /CNW/ - A team of researchers from the University of Alberta is on the cusp of developing a simple test to accurately predict which women will develop preeclampsia - a condition that affects 4 million women a year and can result in the deaths of both mothers and their babies.

The test, which can be administered as early as 15 weeks, is possible thanks to an international study which pinpointed a "metabolic fingerprint" in women who later develop preeclampsia, a condition marked by high blood pressure and high protein levels in urine. There is currently no predictive test for preeclampsia, a leading cause of maternal death worldwide, which can strike at anywhere between 24-40 weeks gestation. And the only way to cure the condition is to deliver the baby - usually weeks or months premature.

Philip Baker, the Dean of the Faculty of Medicine & Dentistry at the U of A, is one of the Principal Investigators and the senior author of the study. He says thousands of lives could be saved.

The research, which appears in the American Heart Association journal Hypertension today, pinpointed a "metabolic fingerprint" - a combination of 14 metabolites or sugars, fats, and amino acids - that appeared in pregnant women who later developed preeclampsia. For a detection rate of 90% for this predictive test, the false-positive rate would be around 21% - 24%. The test is more accurate than pregnancy screening for Down's Syndrome.

"Developing a predictive test for preeclampsia has been called the Obstetrics' Holy Grail," says Louise Kenny, another Principal Investigator who took the lead on the research. She is an adjunct professor at the U of A and a professor of obstetrics and gynecology at the Anu Research Center, University College Cork, in Cork, Ireland.

Researchers involved in a metabolomics initiative at the U of A are on the cusp of making the test simple, quick and inexpensive.

The study involved a team of researchers from Ireland, the UK, New Zealand, Australia and Alberta and was funded by various groups.

www.med.ualberta.ca

For further information:
Raquel Maurier, Communications Associate

780-492-5986 (office), cell 780-224-7751; raquel.maurier@ualberta.ca

Contact information

Contact Us
Mailing address

260 Adelaide Street East, No. 8, Toronto ON M5A 1N1

Telephone number
416-864-9667
Fax number
416-368-4443

Subscribe Today

  • Healthcare Policy / Politiques de Santé

    Journal of health services, management and policy research

Stay Connected

Newsletter
© 2026
Longwoods Publishing Corporation
  • Institutional Users
  • About Us
  • Subscription Information
  • Advertise
  • Reprints
  • Partners
  • Terms
  • Privacy